跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,644 条关于
“Akeso Therapeutics”
全部
16,644
临床试验
3,571
药物
3,118
机构
1,125
资讯
8,830
去年
China's Biotech Surge Forces US Companies to Pivot Towards Novel Innovation
去年
Akeso Secures FDA Approval for Novel Cancer Drug While Partner Summit Therapeutics Faces Sharp Stock Decline
去年
Bristol Myers Squibb Partners with BioNTech in $11.1 Billion Deal for Dual-Target Cancer Immunotherapy
去年
Akeso Reports Positive Phase 3 Results for Ivonescimab in Lung Cancer, Building on Recent FDA Approval Success
去年
Former Seagen CEO Leads Ottimo Pharma's Novel Cancer Immunotherapy Development
11个月前
CD47 Inhibitor Pipeline Expands to Over 80 Drugs as Market Anticipates First Approval by 2028
去年
Akeso Biopharma Secures $250 Million to Advance Global Clinical Trials
去年
Akeso's Ivonescimab Enrolls First Patient in Phase 3 Biliary Tract Cancer Trial
去年
Akeso Initiates Phase 3 Trial of Ivonescimab Plus Ligufalimab in Head and Neck Cancer
2年前
Akeso's Bispecific Antibodies Show Promise in Lung and Colorectal Cancers
第 1 页,共 883 页
上一页
下一页